Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase IIb trial of MLE-4901 in patients with vasomotor symptoms

Trial Profile

A phase IIb trial of MLE-4901 in patients with vasomotor symptoms

Phase of Trial: Phase II

Latest Information Update: 08 Nov 2017

At a glance

  • Drugs Pavinetant (Primary)
  • Indications Hot flashes; Vasomotor symptoms
  • Focus Therapeutic Use
  • Sponsors Millendo Therapeutics
  • Most Recent Events

    • 08 Nov 2017 Status changed from planning to discontinued, as reported in a Millendo Therapeutics media release.
    • 08 Apr 2017 New trial record
    • 03 Apr 2017 According to a Millendo Therapeutics media release, this trial is expected to initiate later in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top